Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.985 USD | -5.92% | -5.28% | +12.69% |
04-24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
04-24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.69% | 1.06B | |
+17.69% | 47.02B | |
+48.77% | 41.86B | |
+1.02% | 41.76B | |
-4.27% | 28.8B | |
+11.89% | 26.05B | |
-21.42% | 19.15B | |
+4.29% | 12.55B | |
+28.28% | 12.34B | |
-4.43% | 11.82B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Centessa Pharmaceuticals Doses First Patient in Phase 3 Trial of Lixivaptan; Payment Triggered